Clinical Trial Analysis
Insights for "Boehringer Ingelheim"
Overview
Total Trials
1,874
All registered studies
Active Recruiting
104
5.5%
Currently enrolling patients
Completed
1,963
104.7%
Studies finished
Phase 3 Studies
20.6%
Advanced phase trials
Key Insights
Leading Region
USA
Most active geographical area
Top Organization
Boehringer Ingelheim
Most active research sponsor
Distribution Analysis
Study Phases
Trial distribution by development phase
Phase 1
1,04355.7%
Phase 3
38620.6%
Phase 2
30216.1%
Phase 4
1286.8%
Not Applicable
140.7%
Early Phase 1
10.1%
Phase 1
1,04355.7%
Phase 3
38620.6%
Phase 2
30216.1%
Phase 4
1286.8%
Not Applicable
140.7%
Early Phase 1
10.1%
Recruitment Status
Current enrollment and completion status
Total: 2,253
Geographic & Sponsor Analysis
Geographic Distribution
Trial activity by country
Top Sponsors
Most active research organizations
Rank
Company
Count
1
Boehringer Ingelheim
2226
2
Sprout Pharmaceuticals, Inc
12
3
AbbVie
3
4
Gedeon Richter Plc.
3
5
Dexa Medica Group
2
6
Genuine Research Center, Egypt
2
7
Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital
1
8
Hallym University Kangnam Sacred Heart Hospital
1
9
Humanis Saglık Anonim Sirketi
1
10
Joint Stock Company "Farmak"
1
Medical Focus Areas
Medical Conditions
Most studied disease areas
Rank
Condition
Count
1
Healthy
781
2
Pulmonary Disease, Chronic Obstructive
232
3
Diabetes Mellitus, Type 2
125
4
Hypertension
121
5
HIV Infections
67
6
Asthma
62
7
Neoplasms
57
8
Carcinoma, Non-Small-Cell Lung
56
9
Atrial Fibrillation
45
10
Parkinson Disease
40
Treatment Types
Most common interventions
Rank
Intervention
Count
1
Placebo
538
2
Empagliflozin
47
3
Telmisartan
46
4
Nintedanib
38
5
Linagliptin
31
6
BI 10773
30
7
BIBW 2992
29
8
Ritonavir
28
9
Tiotropium
24
10
BI 1015550
22